Genome-wide Association Studies-GWAS
Pharmacogenomics: Identification of New Drug Targets
Genomics
Next-generation Sequencing
Pharmacogenetics and Pharmacogenomics: Overview
Behavioral Genetics and Its Designs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 3, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Xin Tu1, Li-Song Shi, Fan Wang
1Center for Human Genome Research and College of Life Science and Technology, Key Laboratory of Molecular Biophysics of Ministry of Education, Cardio-X Institute, Huazhong University of Science and Technology, Wuhan 430074, China.
Genomewide association studies (GWAS) identify genetic variants for complex diseases using millions of single nucleotide polymorphisms (SNPs). This review discusses challenges in GWAS research methods, subjects, markers, and analysis.
Area of Science:
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018